Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Walt Disney
DIS
|
$1.13B |
| 2 |
UnitedHealth
UNH
|
$379M |
| 3 |
Meta Platforms (Facebook)
META
|
$325M |
| 4 |
Wabtec
WAB
|
$303M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$216M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$558M |
| 2 |
Coca-Cola
KO
|
$358M |
| 3 |
ULTI
Ultimate Software Group Inc
ULTI
|
$326M |
| 4 |
ATHN
Athenahealth, Inc.
ATHN
|
$323M |
| 5 |
Starbucks
SBUX
|
$312M |
Sector Composition
| 1 | Technology | 24.08% |
| 2 | Healthcare | 17.92% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Sempra
SRE
$52.9B
| $85M | 0.05% |
1,350,652
+58,078
| +4% | +$3.65M |
|
|
XEC
427
DELISTED
CIMAREX ENERGY CO
XEC
| $84.8M | 0.05% |
1,213,208
+11,639
| +1% | +$814K |
|
428
Regions Financial
RF
$24.1B
| $84.7M | 0.05% |
5,986,468
-2,815,683
| -32% | -$39.8M |
|
429
Descartes Systems
DSGX
$9.26B
| $84.6M | 0.05% |
2,326,331
+76,463
| +3% | +$2.78M |
|
430
Roper Technologies
ROP
$55.8B
| $84.6M | 0.05% |
247,229
-9,025
| -4% | -$3.09M |
|
431
Zebra Technologies
ZBRA
$16B
| $84.4M | 0.05% |
403,256
| – | – |
|
432
Saia
SAIA
$8.34B
| $84.4M | 0.05% |
1,381,118
+215,939
| +19% | +$13.2M |
|
433
Yum! Brands
YUM
$40.1B
| $84.3M | 0.05% |
845,079
+591,961
| +234% | +$59.1M |
|
434
Live Nation Entertainment
LYV
$37.9B
| $84.2M | 0.05% |
1,325,358
+477,947
| +56% | +$30.4M |
|
435
Glaukos
GKOS
$5.39B
| $84.2M | 0.05% |
1,074,445
-1,041,547
| -49% | -$81.6M |
|
436
Puma Biotechnology
PBYI
$253M
| $84.2M | 0.05% |
2,170,423
+308,479
| +17% | +$12M |
|
437
AMC Entertainment Holdings
AMC
$1.41B
| $84M | 0.05% |
565,798
-1,436
| -0.3% | -$213K |
|
438
UGI
UGI
$7.43B
| $84M | 0.05% |
1,515,938
+481,422
| +47% | +$26.7M |
|
439
Goldman Sachs
GS
$223B
| $83.7M | 0.05% |
435,959
+14,608
| +3% | +$2.8M |
|
440
Enanta Pharmaceuticals
ENTA
$189M
| $83.5M | 0.05% |
874,397
+126,804
| +17% | +$12.1M |
|
441
Okta
OKTA
$16.1B
| $83.3M | 0.05% |
1,006,743
-50,841
| -5% | -$4.21M |
|
442
Fair Isaac
FICO
$36.8B
| $83M | 0.05% |
305,549
-2,395
| -0.8% | -$651K |
|
443
Nomad Foods
NOMD
$2.21B
| $82.9M | 0.05% |
4,051,746
-375,900
| -8% | -$7.69M |
|
|
NTUS
444
DELISTED
Natus Medical Inc
NTUS
| $82.8M | 0.05% |
3,263,484
-5,702
| -0.2% | -$145K |
|
445
Nektar Therapeutics
NKTR
$764M
| $82.8M | 0.05% |
164,191
-4,273
| -3% | -$2.15M |
|
446
Digital Realty Trust
DLR
$55.7B
| $82.4M | 0.05% |
692,207
+196,481
| +40% | +$23.4M |
|
447
Masimo
MASI
$8B
| $81.7M | 0.05% |
590,599
+61,762
| +12% | +$8.54M |
|
448
Northrop Grumman
NOC
$83.2B
| $80.6M | 0.04% |
299,127
-376,493
| -56% | -$102M |
|
|
TIF
449
DELISTED
Tiffany & Co.
TIF
| $80.1M | 0.04% |
758,456
-325,095
| -30% | -$34.3M |
|
450
Marsh & McLennan
MMC
$100B
| $79.9M | 0.04% |
851,274
-366,215
| -30% | -$34.4M |
|